-
1
-
-
84983726731
-
Recent advances in the research of hepatitis B virus-related hepatocellular carcinoma: Epidemiologic and molecular biological aspects
-
21034965 10.1016/B978-0-12-380888-2.00002-9 1:CAS:528: DC%2BC3MXitlSltA%3D%3D
-
Kao JH, Chen PJ, Chen DS. Recent advances in the research of hepatitis B virus-related hepatocellular carcinoma: epidemiologic and molecular biological aspects. Adv Cancer Res. 2010;108:21-72.
-
(2010)
Adv Cancer Res
, vol.108
, pp. 21-72
-
-
Kao, J.H.1
Chen, P.J.2
Chen, D.S.3
-
2
-
-
0014376546
-
Hepatitis and leukemia: Their relation to Australia antigen
-
5247325 1:STN:280:DyaF1M%2FlsVSqsg%3D%3D
-
Blumberg BS, Sutnick AI, London WT. Hepatitis and leukemia: their relation to Australia antigen. Bull N Y Acad Med. 1968;44:1566-86.
-
(1968)
Bull N y Acad Med
, vol.44
, pp. 1566-1586
-
-
Blumberg, B.S.1
Sutnick, A.I.2
London, W.T.3
-
3
-
-
29944436855
-
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level
-
16391218 10.1001/jama.295.1.65 1:CAS:528:DC%2BD28XhtlKqtQ%3D%3D
-
Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA. 2006;295:65-73.
-
(2006)
JAMA
, vol.295
, pp. 65-73
-
-
Chen, C.J.1
Yang, H.I.2
Su, J.3
Jen, C.L.4
You, S.L.5
Lu, S.N.6
-
4
-
-
0036293243
-
Global control of hepatitis B virus infection
-
12127351 10.1016/S1473-3099(02)00315-8
-
Kao JH, Chen DS. Global control of hepatitis B virus infection. Lancet Infect Dis. 2002;2:395-403.
-
(2002)
Lancet Infect Dis
, vol.2
, pp. 395-403
-
-
Kao, J.H.1
Chen, D.S.2
-
5
-
-
84860337613
-
New insight in the pathobiology of hepatitis B virus infection
-
22504921 10.1136/gutjnl-2012-302056 1:CAS:528:DC%2BC38Xptl2jurc%3D
-
Dandri M, Locarnini S. New insight in the pathobiology of hepatitis B virus infection. Gut. 2012;61(Suppl 1):i6-17.
-
(2012)
Gut
, vol.61
, Issue.SUPPL. 1
-
-
Dandri, M.1
Locarnini, S.2
-
6
-
-
0027422748
-
From hepatitis to hepatoma: Lessons from type B viral hepatitis
-
8211155 10.1126/science.8211155 1:CAS:528:DyaK3sXms1OltLg%3D
-
Chen DS. From hepatitis to hepatoma: lessons from type B viral hepatitis. Science. 1993;262:369-70.
-
(1993)
Science
, vol.262
, pp. 369-370
-
-
Chen, D.S.1
-
7
-
-
59749096640
-
Hepatitis B virus infection
-
19217993 10.1016/S0140-6736(09)60207-5 1:CAS:528:DC%2BD1MXhvFGltLk%3D
-
Liaw YF, Chu CM. Hepatitis B virus infection. Lancet. 2009;373:582-92.
-
(2009)
Lancet
, vol.373
, pp. 582-592
-
-
Liaw, Y.F.1
Chu, C.M.2
-
8
-
-
77957901418
-
Hepatitis B e antigen seroconversion: A critical event in chronic hepatitis B virus infection
-
20238245 10.1007/s10620-010-1179-4 1:CAS:528:DC%2BC3cXhtF2lurvO
-
Liaw YF, Lau GK, Kao JH, Gane E. Hepatitis B e antigen seroconversion: a critical event in chronic hepatitis B virus infection. Dig Dis Sci. 2010;55:2727-34.
-
(2010)
Dig Dis Sci
, vol.55
, pp. 2727-2734
-
-
Liaw, Y.F.1
Lau, G.K.2
Kao, J.H.3
Gane, E.4
-
9
-
-
35648952818
-
Predictive factors for reactivation of hepatitis B following hepatitis B e antigen seroconversion in chronic hepatitis B
-
17935720 10.1053/j.gastro.2007.08.039 1:CAS:528:DC%2BD2sXhsVGqtrzO
-
Chu CM, Liaw YF. Predictive factors for reactivation of hepatitis B following hepatitis B e antigen seroconversion in chronic hepatitis B. Gastroenterology. 2007;133:1458-65.
-
(2007)
Gastroenterology
, vol.133
, pp. 1458-1465
-
-
Chu, C.M.1
Liaw, Y.F.2
-
10
-
-
75449105399
-
Age-specific prognosis following spontaneous hepatitis B e antigen seroconversion in chronic hepatitis B
-
19918971 10.1002/hep.23348
-
Chen YC, Chu CM, Liaw YF. Age-specific prognosis following spontaneous hepatitis B e antigen seroconversion in chronic hepatitis B. Hepatology. 2010;51:435-44.
-
(2010)
Hepatology
, vol.51
, pp. 435-444
-
-
Chen, Y.C.1
Chu, C.M.2
Liaw, Y.F.3
-
11
-
-
84983727403
-
Serum hepatitis B virus-DNA levels correlate with long-term adverse outcomes in spontaneous hepatitis B e antigen seroconverters
-
22095766 10.1093/infdis/jir687 1:CAS:528:DC%2BC3MXhs12ht7%2FP
-
Tseng TC, Liu CJ, Chen CL, Wang CC, Su TH, Kuo SF, et al. Serum hepatitis B virus-DNA levels correlate with long-term adverse outcomes in spontaneous hepatitis B e antigen seroconverters. J Infect Dis. 2012;205:54-63.
-
(2012)
J Infect Dis
, vol.205
, pp. 54-63
-
-
Tseng, T.C.1
Liu, C.J.2
Chen, C.L.3
Wang, C.C.4
Su, T.H.5
Kuo, S.F.6
-
12
-
-
0036614299
-
Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B
-
12029639 10.1053/jhep.2002.33638
-
Hsu YS, Chien RN, Yeh CT, Sheen IS, Chiou HY, Chu CM, et al. Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B. Hepatology. 2002;35:1522-7.
-
(2002)
Hepatology
, vol.35
, pp. 1522-1527
-
-
Hsu, Y.S.1
Chien, R.N.2
Yeh, C.T.3
Sheen, I.S.4
Chiou, H.Y.5
Chu, C.M.6
-
13
-
-
67649199520
-
Long-term outcome of hepatitis B e antigen-negative hepatitis B surface antigen carriers in relation to changes of alanine aminotransferase levels over time
-
19378345 10.1002/hep.22878 1:CAS:528:DC%2BD1MXotVCmtLY%3D
-
Tai DI, Lin SM, Sheen IS, Chu CM, Lin DY, Liaw YF. Long-term outcome of hepatitis B e antigen-negative hepatitis B surface antigen carriers in relation to changes of alanine aminotransferase levels over time. Hepatology. 2009;49:1859-67.
-
(2009)
Hepatology
, vol.49
, pp. 1859-1867
-
-
Tai, D.I.1
Lin, S.M.2
Sheen, I.S.3
Chu, C.M.4
Lin, D.Y.5
Liaw, Y.F.6
-
14
-
-
2642580655
-
Natural history of hepatitis B e antigen to antibody seroconversion in patients with normal serum aminotransferase levels
-
15178498 10.1016/j.amjmed.2003.12.040 1:CAS:528:DC%2BD2cXkslWltLs%3D
-
Chu CM, Hung SJ, Lin J, Tai DI, Liaw YF. Natural history of hepatitis B e antigen to antibody seroconversion in patients with normal serum aminotransferase levels. Am J Med. 2004;116:829-34.
-
(2004)
Am J Med
, vol.116
, pp. 829-834
-
-
Chu, C.M.1
Hung, S.J.2
Lin, J.3
Tai, D.I.4
Liaw, Y.F.5
-
15
-
-
77950684115
-
Hepatitis B surface antigen seroclearance during chronic HBV infection
-
20386068 10.3851/IMP1497
-
Chu CM, Liaw YF. Hepatitis B surface antigen seroclearance during chronic HBV infection. Antivir Ther. 2010;15:133-43.
-
(2010)
Antivir Ther
, vol.15
, pp. 133-143
-
-
Chu, C.M.1
Liaw, Y.F.2
-
16
-
-
77957938721
-
A longitudinal study on the natural history of serum hepatitis B surface antigen changes in chronic hepatitis B
-
20648555 10.1002/hep.23803 1:CAS:528:DC%2BC3cXhtlejsrvL
-
Chan HL, Wong VW, Wong GL, Tse CH, Chan HY, Sung JJ. A longitudinal study on the natural history of serum hepatitis B surface antigen changes in chronic hepatitis B. Hepatology. 2010;52:1232-41.
-
(2010)
Hepatology
, vol.52
, pp. 1232-1241
-
-
Chan, H.L.1
Wong, V.W.2
Wong, G.L.3
Tse, C.H.4
Chan, H.Y.5
Sung, J.J.6
-
17
-
-
77949655619
-
Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: A perspective on Asia
-
20206400 10.1016/j.jhep.2010.01.007 1:CAS:528:DC%2BC3cXjvFKmsLY%3D
-
Nguyen T, Thompson AJ, Bowden S, Croagh C, Bell S, Desmond PV, et al. Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: a perspective on Asia. J Hepatol. 2010;52:508-13.
-
(2010)
J Hepatol
, vol.52
, pp. 508-513
-
-
Nguyen, T.1
Thompson, A.J.2
Bowden, S.3
Croagh, C.4
Bell, S.5
Desmond, P.V.6
-
18
-
-
77949656255
-
Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: A European perspective
-
20207438 10.1016/j.jhep.2010.01.014 1:CAS:528:DC%2BC3cXjvFKmsLc%3D
-
Jaroszewicz J, Calle Serrano B, Wursthorn K, Deterding K, Schlue J, Raupach R, et al. Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective. J Hepatol. 2010;52:514-22.
-
(2010)
J Hepatol
, vol.52
, pp. 514-522
-
-
Jaroszewicz, J.1
Calle Serrano, B.2
Wursthorn, K.3
Deterding, K.4
Schlue, J.5
Raupach, R.6
-
19
-
-
77955494346
-
Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers
-
20451520 10.1053/j.gastro.2010.04.052 1:CAS:528:DC%2BC3cXpsVGnu7o%3D
-
Brunetto MR, Oliveri F, Colombatto P, Moriconi F, Ciccorossi P, Coco B, et al. Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers. Gastroenterology. 2010;139:483-90.
-
(2010)
Gastroenterology
, vol.139
, pp. 483-490
-
-
Brunetto, M.R.1
Oliveri, F.2
Colombatto, P.3
Moriconi, F.4
Ciccorossi, P.5
Coco, B.6
-
20
-
-
0036789020
-
Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection
-
12360470 10.1053/gast.2002.36026
-
Chen YC, Sheen IS, Chu CM, Liaw YF. Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection. Gastroenterology. 2002;123:1084-9.
-
(2002)
Gastroenterology
, vol.123
, pp. 1084-1089
-
-
Chen, Y.C.1
Sheen, I.S.2
Chu, C.M.3
Liaw, Y.F.4
-
21
-
-
0001731999
-
Delayed clearance of serum HBsAg in compensated cirrhosis B: Relation to interferon alpha therapy and disease prognosis. European concerted action on viral hepatitis (EUROHEP)
-
9647014 10.1111/j.1572-0241.1998.00272.x 1:STN:280:DyaK1czgvFahuw%3D%3D
-
Fattovich G, Giustina G, Sanchez-Tapias J, Quero C, Mas A, Olivotto PG, et al. Delayed clearance of serum HBsAg in compensated cirrhosis B: relation to interferon alpha therapy and disease prognosis. European concerted action on viral hepatitis (EUROHEP). Am J Gastroenterol. 1998;93:896-900.
-
(1998)
Am J Gastroenterol
, vol.93
, pp. 896-900
-
-
Fattovich, G.1
Giustina, G.2
Sanchez-Tapias, J.3
Quero, C.4
Mas, A.5
Olivotto, P.G.6
-
22
-
-
0031837430
-
Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis
-
9657117 10.1002/hep.510280130 1:CAS:528:DyaK1cXks1aqtrw%3D
-
Huo TI, Wu JC, Lee PC, Chau GY, Lui WY, Tsay SH, et al. Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis. Hepatology. 1998;28:231-6.
-
(1998)
Hepatology
, vol.28
, pp. 231-236
-
-
Huo, T.I.1
Wu, J.C.2
Lee, P.C.3
Chau, G.Y.4
Lui, W.Y.5
Tsay, S.H.6
-
23
-
-
2542516261
-
HBsAg seroclearance in chronic hepatitis B in the Chinese: Virological, histological, and clinical aspects
-
15185311 10.1002/hep.20240
-
Yuen MF, Wong DK, Sablon E, Tse E, Ng IO, Yuan HJ, et al. HBsAg seroclearance in chronic hepatitis B in the Chinese: virological, histological, and clinical aspects. Hepatology. 2004;39:1694-701.
-
(2004)
Hepatology
, vol.39
, pp. 1694-1701
-
-
Yuen, M.F.1
Wong, D.K.2
Sablon, E.3
Tse, E.4
Ng, I.O.5
Yuan, H.J.6
-
24
-
-
0025753470
-
Incidence, determinants and significance of delayed clearance of serum HBsAg in chronic hepatitis B virus infection: A prospective study
-
2010157 10.1002/hep.1840130403 1:STN:280:DyaK3M7osVOisA%3D%3D
-
Liaw YF, Sheen IS, Chen TJ, Chu CM, Pao CC. Incidence, determinants and significance of delayed clearance of serum HBsAg in chronic hepatitis B virus infection: a prospective study. Hepatology. 1991;13:627-31.
-
(1991)
Hepatology
, vol.13
, pp. 627-631
-
-
Liaw, Y.F.1
Sheen, I.S.2
Chen, T.J.3
Chu, C.M.4
Pao, C.C.5
-
25
-
-
34248679355
-
HBsAg seroclearance in asymptomatic carriers of high endemic areas: Appreciably high rates during a long-term follow-up
-
17465003 10.1002/hep.21612
-
Chu CM, Liaw YF. HBsAg seroclearance in asymptomatic carriers of high endemic areas: appreciably high rates during a long-term follow-up. Hepatology. 2007;45:1187-92.
-
(2007)
Hepatology
, vol.45
, pp. 1187-1192
-
-
Chu, C.M.1
Liaw, Y.F.2
-
26
-
-
0035818616
-
Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus
-
11694101 1:STN:280:DC%2BD3MnovVOgtA%3D%3D
-
McMahon BJ, Holck P, Bulkow L, Snowball M. Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus. Ann Intern Med. 2001;135:759-68.
-
(2001)
Ann Intern Med
, vol.135
, pp. 759-768
-
-
McMahon, B.J.1
Holck, P.2
Bulkow, L.3
Snowball, M.4
-
27
-
-
44349194322
-
Factors associated with natural seroclearance of hepatitis B surface antigen and prognosis after seroclearance: A prospective follow-up study
-
18613411
-
Kim JH, Lee JH, Park SJ, Bae MH, Do Kim Y, Kim JK, et al. Factors associated with natural seroclearance of hepatitis B surface antigen and prognosis after seroclearance: a prospective follow-up study. Hepatogastroenterology. 2008;55:578-81.
-
(2008)
Hepatogastroenterology
, vol.55
, pp. 578-581
-
-
Kim, J.H.1
Lee, J.H.2
Park, S.J.3
Bae, M.H.4
Do Kim, Y.5
Kim, J.K.6
-
28
-
-
77955483993
-
Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance: A community-based follow-up study
-
20434450 10.1053/j.gastro.2010.04.048
-
Liu J, Yang HI, Lee MH, Lu SN, Jen CL, Wang LY, et al. Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance: a community-based follow-up study. Gastroenterology. 2010;139:474-82.
-
(2010)
Gastroenterology
, vol.139
, pp. 474-482
-
-
Liu, J.1
Yang, H.I.2
Lee, M.H.3
Lu, S.N.4
Jen, C.L.5
Wang, L.Y.6
-
29
-
-
84984552614
-
Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters
-
Tseng TC, Liu CJ, Su TH, Wang CC, Chen CL, Chen PJ, et al. Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters. Gastroenterology. 2011;141(517-525):e2.
-
(2011)
Gastroenterology
, vol.141
, Issue.517-525
, pp. 2
-
-
Tseng, T.C.1
Liu, C.J.2
Su, T.H.3
Wang, C.C.4
Chen, C.L.5
Chen, P.J.6
-
30
-
-
84984571825
-
Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load
-
21858846 10.1002/hep.24615
-
Tseng TC, Liu CJ, Yang HC, Su TH, Wang CC, Chen CL, et al. Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load. Hepatology. 2012;55:68-76.
-
(2012)
Hepatology
, vol.55
, pp. 68-76
-
-
Tseng, T.C.1
Liu, C.J.2
Yang, H.C.3
Su, T.H.4
Wang, C.C.5
Chen, C.L.6
-
31
-
-
84865535075
-
A large case-control study on the predictability of hepatitis B surface antigen (HBsAg) levels three years before HBsAg seroclearance
-
Seto WK, Wong DK, Fung J, Hung IF, Fong DY, Yuen JC, et al. A large case-control study on the predictability of hepatitis B surface antigen (HBsAg) levels three years before HBsAg seroclearance. Hepatology. 2012;56:812-9.
-
(2012)
Hepatology
, vol.56
, pp. 812-819
-
-
Seto, W.K.1
Wong, D.K.2
Fung, J.3
Hung, I.F.4
Fong, D.Y.5
Yuen, J.C.6
-
32
-
-
79960113229
-
Viral determinants of hepatitis B surface antigen seroclearance in hepatitis B e antigen-negative chronic hepatitis B patients
-
10.1093/infdis/jir283
-
Lik-Yuen Chan H, Lai-Hung Wong G, Tse CH, Chan HY, Wai-Sun Wong V. Viral determinants of hepatitis B surface antigen seroclearance in hepatitis B e antigen-negative chronic hepatitis B patients. J Infect Dis. 2011;204:408-14.
-
(2011)
J Infect Dis
, vol.204
, pp. 408-414
-
-
Lik-Yuen Chan, H.1
Lai-Hung Wong, G.2
Tse, C.H.3
Chan, H.Y.4
Wai-Sun Wong, V.5
-
33
-
-
84555207426
-
Quantitative hepatitis B surface antigen levels are significant independent predictors of HBV DNA and HBsAg seroclearance in chronic hepatitis B
-
Abstract 239
-
Liu J, Lee MH, Batrla-Utermann R, Jen CL, Iloeje U, Lu SN, et al. Quantitative hepatitis B surface antigen levels are significant independent predictors of HBV DNA and HBsAg seroclearance in chronic hepatitis B. Hepatology. 2011;54:Abstract 239.
-
(2011)
Hepatology
, vol.54
-
-
Liu, J.1
Lee, M.H.2
Batrla-Utermann, R.3
Jen, C.L.4
Iloeje, U.5
Lu, S.N.6
-
34
-
-
84858794180
-
Spontaneous clearance of hepatitis B surface antigen during the natural history of chronic hepatitis B virus infection
-
Abstract 731
-
Chang MH, Chiu YC, Wu JF, Lin CY, Ni YH, Chen HL, et al. Spontaneous clearance of hepatitis B surface antigen during the natural history of chronic hepatitis B virus infection. Hepatology. 2011;54:Abstract 731.
-
(2011)
Hepatology
, vol.54
-
-
Chang, M.H.1
Chiu, Y.C.2
Wu, J.F.3
Lin, C.Y.4
Ni, Y.H.5
Chen, H.L.6
-
35
-
-
84857194778
-
Decreasing levels of HBsAg predict HBsAg seroclearance in patients with inactive chronic hepatitis B virus infection
-
21893131 10.1016/j.cgh.2011.08.029 1:CAS:528:DC%2BC38XislSqtbo%3D
-
Chen YC, Jeng WJ, Chu CM, Liaw YF. Decreasing levels of HBsAg predict HBsAg seroclearance in patients with inactive chronic hepatitis B virus infection. Clin Gastroenterol Hepatol. 2012;10:297-302.
-
(2012)
Clin Gastroenterol Hepatol
, vol.10
, pp. 297-302
-
-
Chen, Y.C.1
Jeng, W.J.2
Chu, C.M.3
Liaw, Y.F.4
-
36
-
-
33644858331
-
Predicting cirrhosis risk based on the level of circulating hepatitis B viral load
-
16530509 10.1053/j.gastro.2005.11.016
-
Iloeje UH, Yang HI, Su J, Jen CL, You SL, Chen CJ, et al. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology. 2006;130:678-86.
-
(2006)
Gastroenterology
, vol.130
, pp. 678-686
-
-
Iloeje, U.H.1
Yang, H.I.2
Su, J.3
Jen, C.L.4
You, S.L.5
Chen, C.J.6
-
37
-
-
70349240414
-
Chronic hepatitis B: Update 2009
-
19714720 10.1002/hep.23190
-
Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology. 2009;50:661-2.
-
(2009)
Hepatology
, vol.50
, pp. 661-662
-
-
Lok, A.S.1
McMahon, B.J.2
-
38
-
-
84862664371
-
EASL clinical practice guidelines: Management of chronic hepatitis B virus infection
-
European Association for the Study of the Liver
-
European Association for the Study of the Liver. EASL clinical practice guidelines: management of chronic hepatitis B virus infection. J Hepatol. 2012;57:167-85.
-
(2012)
J Hepatol
, vol.57
, pp. 167-185
-
-
-
39
-
-
84865376141
-
Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2012 update
-
Liaw YF, Kao JH, Piratvisuth T, Chan HL, Chien RN, Liu CJ, et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update. Hepatol Int. 2012;6:531-61.
-
(2012)
Hepatol Int.
, vol.6
, pp. 531-561
-
-
Liaw, Y.F.1
Kao, J.H.2
Piratvisuth, T.3
Chan, H.L.4
Chien, R.N.5
Liu, C.J.6
-
40
-
-
84983726112
-
High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load
-
22333950
-
Tseng TC, Liu CJ, Yang HC, Su TH, Wang CC, Chen CL, et al. High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load. Gastroenterology. 2012;142(1140-1149):e3.
-
(2012)
Gastroenterology
, vol.142
, Issue.1140-1149
, pp. 3
-
-
Tseng, T.C.1
Liu, C.J.2
Yang, H.C.3
Su, T.H.4
Wang, C.C.5
Chen, C.L.6
-
41
-
-
77951670101
-
Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death
-
20114048 10.1053/j.gastro.2010.01.042
-
Chen JD, Yang HI, Iloeje UH, You SL, Lu SN, Wang LY, et al. Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death. Gastroenterology. 2010;138:1747-54.
-
(2010)
Gastroenterology
, vol.138
, pp. 1747-1754
-
-
Chen, J.D.1
Yang, H.I.2
Iloeje, U.H.3
You, S.L.4
Lu, S.N.5
Wang, L.Y.6
-
42
-
-
84860112790
-
Quantitative serum levels of hepatitis B virus DNA and surface antigen are independent risk predictors of hepatocellular carcinoma
-
Abstract 1095
-
Chen CJ, Lee MH, Jessica L, Ricard B-U, Jen CL, Uchenna I, et al. Quantitative serum levels of hepatitis B virus DNA and surface antigen are independent risk predictors of hepatocellular carcinoma. Hepatology. 2011;54:Abstract 1095.
-
(2011)
Hepatology
, vol.54
-
-
Chen, C.J.1
Lee, M.H.2
Jessica, L.3
Ricard, B.-U.4
Jen, C.L.5
Uchenna, I.6
-
43
-
-
77952514489
-
Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection
-
20368541 10.1200/JCO.2009.27.4456
-
Yang HI, Sherman M, Su J, Chen PJ, Liaw YF, Iloeje UH, et al. Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection. J Clin Oncol. 2010;28:2437-44.
-
(2010)
J Clin Oncol
, vol.28
, pp. 2437-2444
-
-
Yang, H.I.1
Sherman, M.2
Su, J.3
Chen, P.J.4
Liaw, Y.F.5
Iloeje, U.H.6
-
44
-
-
84984550778
-
Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): Development and validation of a predictive score
-
21497551 10.1016/S1470-2045(11)70077-8
-
Yang HI, Yuen MF, Chan HL, Han KH, Chen PJ, Kim DY, et al. Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score. Lancet Oncol. 2011;12:568-74.
-
(2011)
Lancet Oncol
, vol.12
, pp. 568-574
-
-
Yang, H.I.1
Yuen, M.F.2
Chan, H.L.3
Han, K.H.4
Chen, P.J.5
Kim, D.Y.6
-
45
-
-
80053577592
-
Changes in serum levels of HBV DNA and alanine aminotransferase determine risk for hepatocellular carcinoma
-
1248 e1-2
-
Chen CF, Lee WC, Yang HI, Chang HC, Jen CL, Iloeje UH, et al. Changes in serum levels of HBV DNA and alanine aminotransferase determine risk for hepatocellular carcinoma. Gastroenterology. 2011;141:1240-8, 1248 e1-2.
-
(2011)
Gastroenterology
, vol.141
, pp. 1240-1248
-
-
Chen, C.F.1
Lee, W.C.2
Yang, H.I.3
Chang, H.C.4
Jen, C.L.5
Iloeje, U.H.6
-
46
-
-
84872498457
-
Serum hepatitis B surface antigen (HBsAg) kinetics in hepatitis B e antigen (HBeAg)-negative chronic hepatitis B
-
(in press). doi: 10.1007/s12072-012-9373-4
-
Seto WT, Wong KH, Fung J, Hung FN, Yuen CH, Tong T, et al. Serum hepatitis B surface antigen (HBsAg) kinetics in hepatitis B e antigen (HBeAg)-negative chronic hepatitis B. Hepatol Int. 2012 (in press). doi: 10.1007/s12072-012-9373-4.
-
(2012)
Hepatol Int.
-
-
Seto, W.T.1
Wong, K.H.2
Fung, J.3
Hung, F.N.4
Yuen, C.H.5
Tong, T.6
-
47
-
-
80051498209
-
Recent advances in the treatment of chronic hepatitis B
-
21682661 10.1517/14656566.2011.590474
-
Lin CL, Kao JH. Recent advances in the treatment of chronic hepatitis B. Expert Opin Pharmacother. 2011;12:2025-40.
-
(2011)
Expert Opin Pharmacother
, vol.12
, pp. 2025-2040
-
-
Lin, C.L.1
Kao, J.H.2
-
48
-
-
80054724912
-
Hepatitis B surface antigen quantification: Why and how to use it in 2011 - A core group report
-
21718667 10.1016/j.jhep.2011.06.006
-
Chan HL, Thompson A, Martinot-Peignoux M, Piratvisuth T, Cornberg M, Brunetto MR, et al. Hepatitis B surface antigen quantification: why and how to use it in 2011 - a core group report. J Hepatol. 2011;55:1121-31.
-
(2011)
J Hepatol
, vol.55
, pp. 1121-1131
-
-
Chan, H.L.1
Thompson, A.2
Martinot-Peignoux, M.3
Piratvisuth, T.4
Cornberg, M.5
Brunetto, M.R.6
-
49
-
-
84859567945
-
Quantification of serum hepatitis B surface antigen: Is it useful for the management of chronic hepatitis B?
-
22180061 10.1136/gutjnl-2011-301096 1:CAS:528:DC%2BC38Xps1Kiu70%3D
-
Janssen HL, Sonneveld MJ, Brunetto MR. Quantification of serum hepatitis B surface antigen: is it useful for the management of chronic hepatitis B? Gut. 2012;61:641-5.
-
(2012)
Gut
, vol.61
, pp. 641-645
-
-
Janssen, H.L.1
Sonneveld, M.J.2
Brunetto, M.R.3
-
50
-
-
80055059164
-
Shorter durations and lower doses of peginterferon alfa-2a are associated with inferior hepatitis B e antigen seroconversion rates in hepatitis B virus genotypes B or C
-
22045673 10.1002/hep.24555 1:CAS:528:DC%2BC3MXhtlygsbrJ
-
Liaw YF, Jia JD, Chan HL, Han KH, Tanwandee T, Chuang WL, et al. Shorter durations and lower doses of peginterferon alfa-2a are associated with inferior hepatitis B e antigen seroconversion rates in hepatitis B virus genotypes B or C. Hepatology. 2011;54:1591-9.
-
(2011)
Hepatology
, vol.54
, pp. 1591-1599
-
-
Liaw, Y.F.1
Jia, J.D.2
Chan, H.L.3
Han, K.H.4
Tanwandee, T.5
Chuang, W.L.6
-
51
-
-
84879841799
-
Hepatitis B surface antigen: Association with sustained response to peginterferon alfa-2a in hepatitis B e antigen-positive patients
-
(In press). doi: 10.1007/s12072-011-9280-0
-
Piratvisuth T, Marcellin P, Popescu M, Kapprell HP, Rothe V, Lu ZM. Hepatitis B surface antigen: association with sustained response to peginterferon alfa-2a in hepatitis B e antigen-positive patients. Hepatol Int. 2012 (In press). doi: 10.1007/s12072-011-9280-0.
-
(2012)
Hepatol Int.
-
-
Piratvisuth, T.1
Marcellin, P.2
Popescu, M.3
Kapprell, H.P.4
Rothe, V.5
Lu, Z.M.6
-
52
-
-
77955703978
-
Early on-treatment prediction of response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B using HBsAg and HBV DNA levels
-
20683945 10.1002/hep.23722 1:CAS:528:DC%2BC3cXhtV2ju7vO
-
Rijckborst V, Hansen BE, Cakaloglu Y, Ferenci P, Tabak F, Akdogan M, et al. Early on-treatment prediction of response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B using HBsAg and HBV DNA levels. Hepatology. 2010;52:454-61.
-
(2010)
Hepatology
, vol.52
, pp. 454-461
-
-
Rijckborst, V.1
Hansen, B.E.2
Cakaloglu, Y.3
Ferenci, P.4
Tabak, F.5
Akdogan, M.6
-
53
-
-
84859734382
-
Validation of a stopping rule at week 12 using HBsAg and HBV DNA for HBeAg-negative patients treated with peginterferon alfa-2a
-
22245886 10.1016/j.jhep.2011.12.007 1:CAS:528:DC%2BC38XlvFGgtrw%3D
-
Rijckborst V, Hansen BE, Ferenci P, Brunetto MR, Tabak F, Cakaloglu Y, et al. Validation of a stopping rule at week 12 using HBsAg and HBV DNA for HBeAg-negative patients treated with peginterferon alfa-2a. J Hepatol. 2012;56:1006-11.
-
(2012)
J Hepatol
, vol.56
, pp. 1006-1011
-
-
Rijckborst, V.1
Hansen, B.E.2
Ferenci, P.3
Brunetto, M.R.4
Tabak, F.5
Cakaloglu, Y.6
-
54
-
-
84984584244
-
Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B
-
21149920 10.3851/IMP1696 1:CAS:528:DC%2BC3MXitFKhtbk%3D
-
Su TH, Hsu CS, Chen CL, Liu CH, Huang YW, Tseng TC, et al. Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B. Antivir Ther. 2010;15:1133-9.
-
(2010)
Antivir Ther
, vol.15
, pp. 1133-1139
-
-
Su, T.H.1
Hsu, C.S.2
Chen, C.L.3
Liu, C.H.4
Huang, Y.W.5
Tseng, T.C.6
-
55
-
-
78650477355
-
Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B
-
20955704 10.1053/j.gastro.2010.10.011 1:CAS:528:DC%2BC3cXhsFyltLvF
-
Heathcote EJ, Marcellin P, Buti M, Gane E, De Man RA, Krastev Z, et al. Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B. Gastroenterology. 2011;140:132-43.
-
(2011)
Gastroenterology
, vol.140
, pp. 132-143
-
-
Heathcote, E.J.1
Marcellin, P.2
Buti, M.3
Gane, E.4
De Man, R.A.5
Krastev, Z.6
-
56
-
-
77956592924
-
Kinetics of hepatitis B surface antigen decline during 3 years of telbivudine treatment in hepatitis B e antigen-positive patients
-
20931556 10.1002/hep.23905 1:CAS:528:DC%2BC3cXhsFOnsrrO
-
Wursthorn K, Jung M, Riva A, Goodman ZD, Lopez P, Bao W, et al. Kinetics of hepatitis B surface antigen decline during 3 years of telbivudine treatment in hepatitis B e antigen-positive patients. Hepatology. 2010;52:1611-20.
-
(2010)
Hepatology
, vol.52
, pp. 1611-1620
-
-
Wursthorn, K.1
Jung, M.2
Riva, A.3
Goodman, Z.D.4
Lopez, P.5
Bao, W.6
-
57
-
-
79951669706
-
Kinetics of hepatitis B surface antigen differ between treatment with peginterferon and entecavir
-
21112655 10.1016/j.jhep.2010.07.046 1:CAS:528:DC%2BC3MXit1yqtbs%3D
-
Reijnders JG, Rijckborst V, Sonneveld MJ, Scherbeijn SM, Boucher CA, Hansen BE, et al. Kinetics of hepatitis B surface antigen differ between treatment with peginterferon and entecavir. J Hepatol. 2011;54:449-54.
-
(2011)
J Hepatol
, vol.54
, pp. 449-454
-
-
Reijnders, J.G.1
Rijckborst, V.2
Sonneveld, M.J.3
Scherbeijn, S.M.4
Boucher, C.A.5
Hansen, B.E.6
-
58
-
-
80053894414
-
Quantitative hepatitis B surface antigen levels in patients with chronic hepatitis B after 2 years of entecavir treatment
-
21826112 10.1038/ajg.2011.253 1:CAS:528:DC%2BC3MXht12jtbvN
-
Fung J, Lai CL, Young J, Wong DK, Yuen J, Seto WK, et al. Quantitative hepatitis B surface antigen levels in patients with chronic hepatitis B after 2 years of entecavir treatment. Am J Gastroenterol. 2011;106:1766-73.
-
(2011)
Am J Gastroenterol
, vol.106
, pp. 1766-1773
-
-
Fung, J.1
Lai, C.L.2
Young, J.3
Wong, D.K.4
Yuen, J.5
Seto, W.K.6
-
59
-
-
79955093993
-
Quantitative hepatitis B surface antigen and hepatitis B e antigen titers in prediction of treatment response to entecavir
-
21520167 10.1002/hep.24221
-
Lee JM, Ahn SH, Kim HS, Park H, Chang HY, Kim do Y, et al. Quantitative hepatitis B surface antigen and hepatitis B e antigen titers in prediction of treatment response to entecavir. Hepatology. 2011;53:1486-93.
-
(2011)
Hepatology
, vol.53
, pp. 1486-1493
-
-
Lee, J.M.1
Ahn, S.H.2
Kim, H.S.3
Park, H.4
Chang, H.Y.5
Kim Do, Y.6
-
60
-
-
72949113706
-
Loss of HBsAg antigen during treatment with entecavir or lamivudine in nucleoside-naive HBeAg-positive patients with chronic hepatitis B
-
19622117 10.1111/j.1365-2893.2009.01146.x 1:STN:280: DC%2BC3c%2FhtVGnsg%3D%3D
-
Gish RG, Chang TT, Lai CL, de Man R, Gadano A, Poordad F, et al. Loss of HBsAg antigen during treatment with entecavir or lamivudine in nucleoside-naive HBeAg-positive patients with chronic hepatitis B. J Viral Hepat. 2010;17:16-22.
-
(2010)
J Viral Hepat
, vol.17
, pp. 16-22
-
-
Gish, R.G.1
Chang, T.T.2
Lai, C.L.3
De Man, R.4
Gadano, A.5
Poordad, F.6
-
61
-
-
77958175244
-
HBsAg kinetics of decay and baseline characteristics of HBsAg-positive patients with chronic hepatitis B following 3 years of tenofovir disoproxil fumarate (TDF) treatment
-
10.1016/S0168-8278(10)61007-0
-
Gane E, Heathcote EJ, Marcellin P, Dusheiko G, Jacobson I, de Man R, et al. HBsAg kinetics of decay and baseline characteristics of HBsAg-positive patients with chronic hepatitis B following 3 years of tenofovir disoproxil fumarate (TDF) treatment. J Hepatol. 2010;52(Suppl 1):S388.
-
(2010)
J Hepatol
, vol.52
, Issue.SUPPL. 1
, pp. 388
-
-
Gane, E.1
Heathcote, E.J.2
Marcellin, P.3
Dusheiko, G.4
Jacobson, I.5
De Man, R.6
|